LexDanaLexDanabeta
Inventor

Guoyou Xu

Inventor
Framingham, MA, US

Overview

30→
Patents
2005–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes20%
C07KPeptides14%
C07HSugars11%
C07JSteroids3%
E05FDevices for moving wings into open or closed position3%
C07BGeneral methods of organic chemistry1%
C12NMicroorganisms or enzymes1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
11,078,465Alcohol dehydrogenase mutant and application thereof in synthesis of diaryl chiral alcohols202110,584,145Process for preparation of sulfonylurea bile acid derivatives202010,364,267Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof20199,526,769'Macrocylic oximyl hepatitis C protease inhibitors'20169,242,974'Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives'20168,962,551'Quinoxalinyl derivatives'20158,927,739'Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives'20158,921,573'Processes for the preparation of novel benzimidazole derivatives'20148,809,264'Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors'20148,552,162'Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives'20138,501,681'Macrocyclic hepatitis C virus serine protease inhibitors'20138,268,777'Oximyl macrocyclic derivatives'20128,268,776'Macrocylic oximyl hepatitis C protease inhibitors'20128,236,807'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors'20128,193,346'Process for making macrocyclic oximyl hepatitis C protease inhibitors'20128,124,584'Macrocyclic hepatitis C serine protease inhibitors'2012RE042375'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors'20117,601,709'Macrocyclic hepatitis C serine protease inhibitors'20097,582,605'Phosphorus-containing hepatitis C serine protease inhibitors'20097,566,719'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors'20097,563,877'Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxylamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182'20097,419,962'3,6-bicyclolides'20087,414,030'6-11 Bicyclic erythromycin derivatives'20087,384,921'Polymorphic forms of 6-11 bicyclic ketolide derivatives'20087,273,853'6-11 bicyclic ketolide derivatives'20077,229,972'3,6-Bicyclolides'20077,176,208'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors'20077,135,573'Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine'20067,064,110'6-11 bicycle ketolide derivatives'20066,878,691'6-11 bicyclic ketolide derivatives'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2020Patents assigned to ENANTA PHARM INC (29)· patent assignee history
2005–2009Based in Auburndale, MA, US· patent location history
2006–2008Based in Newton, MA, US· patent location history
2009–2020Based in Framingham, MA, US· patent location history
2012–2016Patents assigned to OR YAT SUN (10)· patent assignee history
2012–2016Patents assigned to WANG ZHE (10)· patent assignee history
2012–2016Patents assigned to XU GUOYOU (10)· patent assignee history
2012–2016Patents assigned to SUN YING (9)· patent assignee history
2021Based in Wuxi, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ENANTA PHARM INC292005–2020
OR YAT SUN102012–2016
WANG ZHE102012–2016
XU GUOYOUself102012–2016
SUN YING92012–2016
Locations
LocationPatentsSpan
Framingham, Massachusetts, US172009–2020
Auburndale, Massachusetts, US92005–2009
Newton, Massachusetts, US32006–2008
Wuxi, CN12021